ML-T7
Modify Date: 2025-08-26 15:11:08
ML-T7 structure
|
Common Name | ML-T7 | ||
|---|---|---|---|---|
| CAS Number | 459789-75-4 | Molecular Weight | 506.33 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H17Cl2NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ML-T7ML-T7 is a potent Tim-3 inhibitor. ML-T7 blocks Tim-3 interactions with PtdSer and CEACAM1.ML-T7 not only enhances the antitumor activity of adoptive transfer therapy with cytotoxic T lymphocytes (CTLs) and CAR T cells but also increases the effector function of T cell. ML-T7 promotes NK cells’ killing activity against tumor cells and DC antigen-presenting capacity. ML-T7 directly exerts antitumor efficacy in preclinical tumor models either alone or in combination with Nivolumab (HY-P9903A). ML-T7 can be used for tumor immunotherapy research[1]. |
| Name | ML-T7 |
|---|
| Description | ML-T7 is a potent Tim-3 inhibitor. ML-T7 blocks Tim-3 interactions with PtdSer and CEACAM1.ML-T7 not only enhances the antitumor activity of adoptive transfer therapy with cytotoxic T lymphocytes (CTLs) and CAR T cells but also increases the effector function of T cell. ML-T7 promotes NK cells’ killing activity against tumor cells and DC antigen-presenting capacity. ML-T7 directly exerts antitumor efficacy in preclinical tumor models either alone or in combination with Nivolumab (HY-P9903A). ML-T7 can be used for tumor immunotherapy research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H17Cl2NO5 |
|---|---|
| Molecular Weight | 506.33 |